{
  "config_id": "MED004.1-THERAPEUTIC-ADHERENCE",
  "config_name": "Therapeutic Adherence - Empagliflozin",
  "scoring_method": "therapeutic_adherence",
  "configuration_json": {
    "method": "therapeutic_adherence",
    "formula": "Average adherence across 1 therapeutic intervention(s)",
    "evaluation_pattern": "daily_multi_therapeutic",
    "schema": {
      "measurement_type": "therapeutic_adherence",
      "evaluation_period": "daily",
      "success_criteria": "adherence_percentage",
      "calculation_method": "multi_therapeutic_average",
      "therapeutics": [
        {
          "name": "Empagliflozin",
          "type": "medication",
          "dose_min": 10,
          "dose_max": 25,
          "unit": "mg",
          "unit_symbol": "mg",
          "rollup": "10-25 mg",
          "frequency": "daily"
        }
      ],
      "therapeutics_count": 1,
      "target_adherence": 90.0,
      "unit": "percent",
      "progress_direction": "maximize",
      "required_days": null,
      "total_days": 30,
      "description": "Adherence tracking for 1 therapeutic intervention(s): Empagliflozin"
    }
  },
  "metadata": {
    "recommendation_text": "Use empagliflozin 10\u201325mg daily as prescribed",
    "recommendation_id": "REC0134.1",
    "analysis": {
      "algorithm_type": "therapeutic_adherence",
      "confidence": 1.0,
      "reasoning": "Multi-therapeutic adherence tracking for 1 intervention(s)"
    },
    "therapeutics_details": [
      {
        "name": "Empagliflozin",
        "type": "medication",
        "dose_min": 10,
        "dose_max": 25,
        "unit": "mg",
        "unit_symbol": "mg",
        "rollup": "10-25 mg",
        "frequency": "daily"
      }
    ],
    "generated_at": "2025-09-27T08:41:31.280960",
    "title": "SGLT2 Inhibitor (empagliflozin)",
    "overview": "SGLT2 inhibitors lower glucose and support weight loss",
    "age_range": "0-150",
    "gender": "male_female",
    "risk_level": NaN
  }
}